Thoracic Oncology

The branch of oncology concerned with the study, diagnosis, and treatment of neoplasms of the thorax.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2018
0204019832018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
1240 Journal of Thoracic Oncology ® • Volume 10, Number 9, September 2015 World Health Organization (WHO) Classifications of… (More)
Is this relevant?
2014
2014
PURPOSE The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-stage non-small-cell lung cancer… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 1
Is this relevant?
2013
2013
Affiliations: Sektion Pneumologie Innenstadt und Thorakale Onkologie, Medizinische Klinik und Poliklinik 5, Ludwig-Maximilians… (More)
  • table 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
S. Novello1, F. Barlesi2, R. Califano3,4, T. Cufer5, S. Ekman6, M. Giaj Levra7, K. Kerr8, S. Popat9, M. Reck10, S. Senan11, G. V… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2010
2010
PURPOSE This phase III trial of concurrent thoracic radiotherapy (TRT) was conducted to compare third-generation chemotherapy… (More)
Is this relevant?
2010
2010
L ung cancer is the leading cause of cancer mortality in Europe and its incidence is rapidly increasing in females [1, 2]. In… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE Docetaxel has shown activity in elderly patients with advanced non-small-cell lung cancer (NSCLC). This randomized phase… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE This multicenter, phase II study was conducted to evaluate the activity of amrubicin, a topoisomerase II inhibitor… (More)
Is this relevant?
2006
2006
Purpose: To evaluate the efficacy and safety of amrubicin, (+)-(7S, 9S)-9-acetyl-9-amino-7-[(2-deoxy-β-D-erythro-pentopyranosyl… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?